Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Brain Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Post-approval studies (Phase 4)Study completedNCT00304291
What this trial is testing

A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

Who this might be right for
Neuromyelitis OpticaMyelitis, TransverseDemyelinating Autoimmune Diseases, CNS+1 more
State University of New York at Buffalo 5
Early research (Phase 1)Ended earlyNCT06193174
What this trial is testing

Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)

Who this might be right for
Recurrent Malignant GliomaGlioblastoma Multiforme of BrainGliosarcoma of Brain+1 more
University of Alabama at Birmingham 1
Testing effectiveness (Phase 2)Study completedNCT00004017
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Peregrine Pharmaceuticals 60
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Very early researchStudy completedNCT04173104
What this trial is testing

PET and MRI Imaging of Brain Tumors Using [18F]PARPi

Who this might be right for
Brain TumorBrain Cancer
Memorial Sloan Kettering Cancer Center 5
Early research (Phase 1)Temporarily pausedNCT04222309
What this trial is testing

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Who this might be right for
GliomaGlioma, MalignantGlioblastoma+4 more
Northwell Health 10
Testing effectiveness (Phase 2)Looking for participantsNCT07416188
What this trial is testing

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Who this might be right for
Recurrent GlioblastomaGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeRelapsed Cancer+12 more
National Institute of Neurological Disorders and Stroke (NINDS) 40
Early research (Phase 1)Study completedNCT02669173
What this trial is testing

Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT03294486
What this trial is testing

Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients

Who this might be right for
GlioblastomaBrain Cancer
Assistance Publique - Hôpitaux de Paris 78
Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Early research (Phase 1)Study completedNCT02197169
What this trial is testing

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors

Who this might be right for
Glioblastoma or Gliosarcoma
DNAtrix, Inc. 37
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT04510051
What this trial is testing

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

Who this might be right for
Malignant Brain NeoplasmRecurrent Malignant Brain NeoplasmRefractory Malignant Brain Neoplasm
City of Hope Medical Center 18
Not applicableActive Not RecruitingNCT03336931
What this trial is testing

PRecISion Medicine for Children With Cancer

Who this might be right for
Childhood CancerChildhood Solid TumorChildhood Brain Tumor+3 more
Sydney Children's Hospitals Network 550
Testing effectiveness (Phase 2)Study completedNCT01081223
What this trial is testing

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Who this might be right for
GliomaHigh Grade AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 12
Testing effectiveness (Phase 2)Study completedNCT00679354
What this trial is testing

Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy

Who this might be right for
Childhood High-grade Cerebellar AstrocytomaChildhood High-grade Cerebral AstrocytomaRecurrent Childhood Anaplastic Astrocytoma+7 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00251797
What this trial is testing

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

Who this might be right for
Brain and Nervous SystemCancer
University of New Mexico 10
Testing effectiveness (Phase 2)WithdrawnNCT00601289
What this trial is testing

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Next Page